Wednesday, August 10th
  • About Us
  • Copyright
  • Disclaimer
  • Privacy Policy
  • Terms&Conditions
  • Contact Us
    • Advertisement
  • Site Map
Biosimilar News
  • Twitter
  • RSS
  • News/Headlines
  • Events
    • Upcoming Events
    • Past Events
  • Guidelines
  • Policies
  • Research/Analysis
USEFUL TIP: In order not to miss any updates, follow us on Twitter or sign up for our Newsletter..

Follow Us

  • Subscribe by RSS Subscribe by RSS
  • Contact us via E-Mail
  • Follow us on Twitter
  • Follow us on LinkedIn
 

Sign up for our newsletter

All-time Popular Posts

  • A biobetter trastuzumab is on the way A biobetter trastuzumab is on the way
  • EGA president calls on Member States to boost market access for biosimilars in the EU EGA president calls on Member States to boost market access for biosimilars in the EU
  • 3rd Forum on Biosimilars 3rd Forum on Biosimilars
  • Pfizer starts biosimilar rituximab Phase I/II trial Pfizer starts biosimilar rituximab Phase I/II trial
  • Indian Biosimilars Market Indian Biosimilars Market
  • World’s first biosimilar antibody* is approved in Korea World’s first biosimilar antibody* is approved in Korea
  • A biosimilar manufacturer: Celltrion A biosimilar manufacturer: Celltrion
  • GPhA applauds Senate HELP Committee for favorably reporting user fee proposals GPhA applauds Senate HELP Committee for favorably reporting user fee proposals

Tags

adalimumab Amgen Celltrion Conference EMA Enbrel Etanercept EU Europe FDA Guideline Herceptin Hospira Humira India infliximab Interchangeability London Mabthera Monoclonal Antibodies Phase III Press Release Remicade Remsima Rituxan rituximab Roche Sandoz South Korea trastuzumab UK USA

Archives

Twitter Updates

Post Tagged with: "EGA"

March 11, 2016 11:07 AM

EGA becomes Medicines For Europe

February 8, 2016 9:05 AM

EBG Biosimilars 2016 – 14th European Biosimilars Group Conference

January 18, 2016 9:29 AM

EGA adopts disclosure requirements for the generic, biosimilar and value added medicines industry

April 27, 2015 7:36 AM

Hospira presents at European Biosimilars Forum, announces new White Paper on extrapolation

March 16, 2015 11:02 AM

EMA has published the revised guideline on biosimilar insulins

© Copyright 2016 — Biosimilar News. All Rights Reserved Powered by Wordpress